NTrans Technologies
PrivateLast Round
Series A
Jun 1, 2021
Total Funding Raised
$2.44M
Company Overview
NTrans Technologies is a biotechnology company that develops a proprietary non-viral delivery platform for the intracellular delivery of gene-editing complexes and other bioactive molecules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NTrans Technologies Comparables
Compare NTrans Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indee Labs | 85% | |
| Kytopen | 84% | |
| Avectas | 82% | |
NTrans Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2021 |
NTrans Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Starfish Innovations | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2025
Monthly visitors increased 1130% MoM, reaching 738.
- Jun 1, 2021
$2.44M round led by Starfish Innovations and uhsf-nl.
NTrans Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NTrans Technologies's valuation, stock price, and market status.